Discover
ANGO
AngioDynamics, Inc.
11.24
2 x 8.33
1 x 11.30
bid
ask
-
0.34
2.94%
2 @ 04:53 PM
11.15 -0.09 (0.81%)
| Ytd | -12.46% | |
| 1y | -4.10% |
11.05
day range
11.73
9.39
52 week range
16.29
| Open | 11.61 | Prev Close | 11.58 | Low | 11.05 | High | 11.73 | Mkt Cap | 472.69M |
| Vol | 890.69K | Avg Vol | 598.58K | EPS | -0.79 | P/E | N/A | Forward P/E | -36.21 |
| Beta | 0.67 | Short Ratio | 2.88 | Inst. Own | 81.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 01-06 | 50-d Avg | 15.01 | 200-d Avg | 12.44 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 80.92M | ||
| Revenues (USD) | 80.92M | ||
| Cost of Revenue | 32.88M | ||
| Gross Profit | 48.04M | ||
| Operating Expenses | 55.34M | ||
| Research and Development Expense | 7.98M | ||
| Selling, General and Administrative Expense | 42.45M | ||
| Operating Income | -7.30M | ||
| Interest Expense | 88.00K | ||
| Income Tax Expense | -199.00K | ||
| Net Income | -7.10M | ||
| Net Income Common Stock | -7.10M | ||
| Net Income Common Stock (USD) | -7.10M | ||
| Consolidated Income | -7.10M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -7.21M | ||
| Earning Before Interest & Taxes (USD) | -7.21M | ||
| Weighted Average Shares | 42.02M | ||
| Weighted Average Shares Diluted | 42.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.97M | ||
| Cash and Equivalents (USD) | 33.97M | ||
| Trade and Non-Trade Receivables | 44.91M | ||
| Current Assets | 143.00M | ||
| Property, Plant & Equipment Net | 27.73M | ||
| Total Assets | 241.93M | ||
| Current Liabilities | 59.69M | ||
| Total Liabilities | 77.97M | ||
| Accumulated Retained Earnings (Deficit) | -473.04M | ||
| Accumulated Other Comprehensive Income | 4.68M | ||
| Shareholders Equity | 163.96M | ||
| Shareholders Equity (USD) | 163.96M | ||
| Assets Non-Current | 98.93M | ||
| Goodwill and Intangible Assets | 61.89M | ||
| Inventory | 54.95M | ||
| Liabilities Non-Current | 18.28M | ||
| Trade and Non-Trade Payables | 26.58M | ||
| Tax Liabilities | 4.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.86M | ||
| Net Cash Flow from Financing | -1.37M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.89M | ||
| Capital Expenditure | -3.15M | ||
| Issuance (Repayment) of Debt Securities | -99.00K | ||
| Net Cash Flow from Investing | -3.15M | ||
| Net Cash Flow from Operations | -15.33M | ||
| Effect of Exchange Rate Changes on Cash | -38.00K | ||
| Share Based Compensation | 4.50M | ||